|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 519/00 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3181567 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17152898.7 |
| Date of filing the European patent application | 2013-09-06 | |
| (97) | Date of publication of the European application | 2017-06-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
| (46) | Date of publication of the claims translation | 2019-07-25 |
| (30) | Number | Date | Country code |
| 201261699038 P | 2012-09-10 | US | |
| 201261728693 P | 2012-11-20 | US | |
| 201361782605 P | 2013-03-14 | US |
| (72) |
Owens, Tim, US
Verner, Erik, US
|
| (73) |
Principia Biopharma Inc.,
100 Morris Street, Morristown, NJ 07960,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pirazolpirimidino junginiai kaip kinazės slopikliai |
| PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 13 | 289.00 EUR |
| 2026-09-06 |